OP0229 THE GROUP FOR RESEARCH AND ASSESSMENT OF PSORIASIS AND PSORIATIC ARTHRITIS (GRAPPA) TREATMENT RECOMMENDATIONS 2021

Coates, L. C.; Soriano, E.; Corp, N.; Bertheussen, H.; Callis-Duffin, K.; Campanholo, C. Barbosa; Chau, J.; Eder, L.; Fernandez, D.; Fitzgerald, O.; Garg, A.; Gladman, D. D.; Goel, N.; Grieb, S.; Helliwell, P.; Husni, M. E.; Jadon, D.; Katz, A.; Laheru, D.; Latella, J.; Leung, Y. Y.; Lindsay, C.; Lubrano, E.; Mazzuoccolo, L.; Mcdonald, R.; Mease, P. J.; O’sullivan, D.; Ogdie, A.; Olsder, W.; Schick, L.; Steinkoenig, I.; De Wit, M.; Van der Windt, D.; Kavanaugh, A.

Abstract

Since the 2015 GRAPPA treatment recommendations were published, therapeutic options and management strategies for psoriatic arthritis (PsA) have advanced considerably.

Citation

Coates, L. C., Soriano, E., Corp, N., Bertheussen, H., Callis-Duffin, K., Campanholo, C. B., …Kavanaugh, A. (2021). OP0229 THE GROUP FOR RESEARCH AND ASSESSMENT OF PSORIASIS AND PSORIATIC ARTHRITIS (GRAPPA) TREATMENT RECOMMENDATIONS 2021. Annals of the Rheumatic Diseases, 80(Suppl 1), 139-140. https://doi.org/10.1136/annrheumdis-2021-eular.4091

• Journal Article Type: Article
• Acceptance Date: May 19, 2021
• Online Publication Date: May 19, 2021
• Publication Date: 2021-06
• Deposit Date: Jun 2, 2023
• Journal: Annals of the Rheumatic Diseases
• Print ISSN: 0003-4967
• Electronic ISSN: 1468-2060
• Publisher: BMJ Publishing Group
• Peer Reviewed: Peer Reviewed
• Volume: 80
• Issue: Suppl 1
• Pages: 139-140
• DOI: https://doi.org/10.1136/annrheumdis-2021-eular.4091
• Keywords: General Biochemistry, Genetics and Molecular Biology; Immunology; Immunology and Allergy; Rheumatology